Status:
RECRUITING
Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block
Lead Sponsor:
University Hospitals Cleveland Medical Center
Conditions:
Pain
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
As per usual care for spine surgery, participants will have their back cleaned with alcohol and a needle will be placed using ultrasound for the ESP block. Through the needle, a small catheter will be...
Eligibility Criteria
Inclusion
- Age range: Adult patients 21-75 years of age
- ASA status: I-III
- Planned lumbar spine fusion involving no more than three levels
- Ability to ambulate prior to surgery
Exclusion
- Previous lumbar spine surgery
- Metastatic cancer with involvement of the lumbar spine
- eGFR \< 60 mL/min/1.73m2
- Active liver disease (hepatitis or cirrhosis)
- Confirmed allergy to ropivacaine, dexmedetomidine or iohexol
- Cognitive impairment resulting in inability to rate pain scores
- Patients receiving 30 mg or more of morphine equivalent daily dosing preoperatively
- Pregnancy
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 25 2026
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT07174440
Start Date
September 15 2025
End Date
January 25 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States, 44106